← All News
Seeking Alpha · 1 min read

OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even

OrthoPediatrics projects $265M-$269M 2026 revenue and reiterates ~$25M adjusted EBITDA as it targets 2026 free cash flow break-even

This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:

Read full article at Seeking Alpha

Related stories

Sources: Bears give RT Wright historic extension

ESPN · just now

Skubal takes loss despite effective Dodgers debut

ESPN · just now

Sources: Falcons' Walker feared to have torn ACL

ESPN · just now

Doncic's ex-fiancée pulls child support petition

ESPN · just now

Yanks boost lineup, get HR from Lombard in debut

ESPN · just now

Freeman, Fighting Irish focus on opener, not CFP

ESPN · just now